Related Experiment Video
Updated: Jun 17, 2025
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Structure-based approaches in synthetic lethality strategies
Francesco Rinaldi1, Stefania Girotto2
1Computational and Chemical Biology, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.
Abstract:
Evolution has fostered robust DNA damage response (DDR) mechanisms to combat DNA lesions. However, disruptions in this intricate machinery can render cells overly reliant on the remaining functional but often less accurate DNA repair pathways. This increased dependence on error-prone pathways may result in improper repair and the accumulation of mutations, fostering genomic instability and facilitating the uncontrolled cell proliferation characteristic of cancer initiation and progression. Strategies based on the concept of synthetic lethality (SL) leverage the inherent genomic instability of cancer cells by targeting alternative pathways, thereby inducing selective death of cancer cells. This review emphasizes recent advancements in structural investigations of pivotal SL targets. The significant contribution of structure-based methodologies to SL research underscores their potential impact in characterizing the growing number of SL targets, largely due to advances in next-generation sequencing. Harnessing these approaches is essential for advancing the development of precise and personalized SL therapeutic strategies.
Insights
Cancer cells often have DNA repair defects, making them vulnerable to synthetic lethality (SL) strategies. Structure-based methods are key to developing new SL cancer therapies by targeting these vulnerabilities.
Area of Science:
- Genomic instability and cancer biology
- Molecular biology and structural biology
- Drug discovery and development
Background:
- DNA damage response (DDR) mechanisms are crucial for cellular integrity.
- Disruptions in DDR can lead to reliance on error-prone repair pathways, causing genomic instability and cancer.
- Synthetic lethality (SL) exploits cancer-specific vulnerabilities for targeted therapy.
Purpose of the Study:
- To review recent advancements in structural investigations of key synthetic lethality targets.
- To highlight the role of structure-based methodologies in advancing SL research.
- To emphasize the potential of these approaches for developing personalized cancer therapies.
Main Methods:
- Review of current literature on structural biology and synthetic lethality.
- Analysis of structure-based methodologies applied to identify and characterize SL targets.
- Integration of next-generation sequencing data with structural insights.
Main Results:
- Recent structural studies have provided critical insights into pivotal SL targets.
- Structure-based approaches are instrumental in characterizing novel SL targets.
- Advances in structural biology facilitate the understanding of DDR pathway dependencies.
Conclusions:
- Structure-based methodologies are essential for advancing synthetic lethality research.
- These approaches are crucial for identifying and validating new SL targets.
- Harnessing structural insights will drive the development of precise, personalized cancer therapeutics.
Related Concept Videos
02:55Synthetic Biology
Golden rice
Golden rice is a genetically modified...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...